2011November 9, 2011Maxygen Announces BARDA Decision Not To Award Contract for Development of MAXY-G34 for Acute Radiation Syndrome November 7, 2011Maxygen Reports Third Quarter 2011 Financial Results October 10, 2011Maxygen Announces Final Rejection of All Claims of Amgen ‘804 Patent in Inter Partes Reexamination Proceeding September 8, 2011Maxygen Announces $10 Million Increase in Stock Repurchase Program August 8, 2011Maxygen Reports Second Quarter 2011 Financial Results May 31, 2011Maxygen Announces $10 Million Stock Repurchase Program May 16, 2011Astellas and Maxygen Announce Completion of Acquisition of Perseid by Astellas May 5, 2011Maxygen Reports First Quarter 2011 Financial Results May 3, 2011Maxygen Submits Proposal to BARDA for Development of MAXY-G34 for Acute Radiation Syndrome March 17, 2011Astellas Exercises Option to Purchase Maxygen’s Interest in Perseid March 8, 2011Maxygen Reports Fourth Quarter and Year End 2010 Financial Results February 4, 2011Maxygen Announces Tax Treatment of 2010 Distributions January 31, 2011Maxygen Announces Initiation of Phase I Clinical Trial
Return to News
|
